Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

Sanofi reception

FDA lifts clinical hold on Sanofi’s haemophilia drug

Phase II and III trials of fitusiran can now resume

1. Blood Test Results

Health literacy… it’s not just plain English

In this day and age, you would think that clear communication would be second nature to us all, but this is not so. In our digital world misunderstanding and confusion...

Cuttsy + Cuttsy

- PMLiVE

Sanifit appoints Alexander Gold chief medical officer

He also serve as president of the Spanish biopharma's US subsidiary

- PMLiVE

MSD supports Jabs for the Boys campaign

Awards HPV Action an educational grant for its HPV awareness work

Not in my backyard

Let’s be honest: the notion that you can import prescription drugs from one country at a cheaper price and pass those savings on to consumers in another country is fraught...

- PMLiVE

Pharma is ‘getting lower returns on R&D’

And Deloitte says the number of drugs in late-stage trials tumbled by 16%

- PMLiVE

Teva cuts 25% of workforce, with Israel taking a heavy toll

But share prices increase by almost 14%

Amazon’s invasion

Jeff Bezos’ new move isn’t the problem you think it is - it’s worse

Bristol-Myers Squibb (BMS) building

BMS adds another Ono drug to its immuno-oncology portfolio

Pharma giant hopes its new candidate can follow in the footsteps of Opdivo

Sanofi reception

Sanofi/Regeneron start first filings for PD-1 drug cemiplimab

The pharma partners begin with a skin cancer filing to the US FDA

Sanofi reception

Sanofi/Regeneron start first filings for PD-1 drug cemiplimab

The pharma partners begin with a skin cancer filing to the US FDA

- PMLiVE

Agios appoints Celgene’s Jackie Fouse

She joins the pharma group’s board of directors

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links